|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1995-2-1
|
|
pubmed:abstractText |
Four patients with chronic schizophrenia were treated with a combination of fluvoxamine, haloperidol, and benztropine. The combination significantly impaired performance on tests of delayed recall memory and attentional function. Haloperidol concentrations in serum were monitored in three patients and were robustly elevated by fluvoxamine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0271-0749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
340-3
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7806690-Adult,
pubmed-meshheading:7806690-Benztropine,
pubmed-meshheading:7806690-Chronic Disease,
pubmed-meshheading:7806690-Cross-Over Studies,
pubmed-meshheading:7806690-Dose-Response Relationship, Drug,
pubmed-meshheading:7806690-Double-Blind Method,
pubmed-meshheading:7806690-Drug Administration Schedule,
pubmed-meshheading:7806690-Drug Therapy, Combination,
pubmed-meshheading:7806690-Fluvoxamine,
pubmed-meshheading:7806690-Haloperidol,
pubmed-meshheading:7806690-Humans,
pubmed-meshheading:7806690-Male,
pubmed-meshheading:7806690-Middle Aged,
pubmed-meshheading:7806690-Neurologic Examination,
pubmed-meshheading:7806690-Psychiatric Status Rating Scales,
pubmed-meshheading:7806690-Schizophrenia,
pubmed-meshheading:7806690-Schizophrenic Psychology
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Coadministration of fluvoxamine increases serum concentrations of haloperidol.
|
|
pubmed:affiliation |
Clinical Brain Disorders Branch, NIMH Neuroscience Center at Saint Elizabeths, Washington, D.C.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
